PURE Bioscience, Inc. OTC:PURE

PURE Bioscience stock price today

$0.09
+0.02
+44.93%
Financial Health
0
1
2
3
4
5
6
7
8
9

PURE Bioscience stock price monthly change

-8.82%
month

PURE Bioscience stock price quarterly change

-8.82%
quarter

PURE Bioscience stock price yearly change

-52.31%
year

PURE Bioscience key metrics

Market Cap
11.13M
Enterprise value
N/A
P/E
-3
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
7.40
Price/Book
6.46
PEG ratio
0.09
EPS
-0.03
Revenue
1.77M
EBITDA
-3.24M
Income
-3.77M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-224.28%
Oper. margin
-223.56%
Gross margin
49.39%
EBIT margin
-223.56%
EBITDA margin
-182.49%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

PURE Bioscience stock price history

PURE Bioscience stock forecast

PURE Bioscience financial statements

PURE Bioscience, Inc. (OTC:PURE): Profit margin
Apr 2023 407K -879K -215.97%
Jul 2023 602K -1.03M -171.43%
Jan 2024 326K -1.00M -307.36%
Apr 2024 441K -857K -194.33%
PURE Bioscience, Inc. (OTC:PURE): Debt to assets
Apr 2023 1824000 569K 31.2%
Jul 2023 1825000 1.55M 85.1%
Jan 2024 1086000 2.40M 221.64%
Apr 2024 920000 3.06M 333.26%
PURE Bioscience, Inc. (OTC:PURE): Cash Flow
Apr 2023 -665K -39K 0
Jul 2023 -744K 43K 1.01M
Jan 2024 -883K 0 0
Apr 2024 -615K 0 500K

PURE Bioscience alternative data

PURE Bioscience, Inc. (OTC:PURE): Employee count
Aug 2023 15
Sep 2023 15
Oct 2023 15
Nov 2023 15
Dec 2023 11
Jan 2024 11
Feb 2024 11
Mar 2024 11
Apr 2024 11
May 2024 11
Jun 2024 11
Jul 2024 11

PURE Bioscience other data

PURE Bioscience, Inc. (OTC:PURE): Insider trades (number of shares)
Period Buy Sel
Dec 2022 50000 0
Mar 2023 60000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
BARTLETT ROBERT F director, officer: CEO
Common Stock 50,000 $0.16 $7,750
Purchase
BLOTNER BERNARD director
Common Stock 10,000 $0.13 $1,300
Purchase
LEE TOM Y director, 10 percent owner, off..
Common Stock 50,000 $0.13 $6,550
Purchase
LEE TOM Y director, 10 percent owner, off..
Common Stock 185,000 $0.2 $36,630
Purchase
LEE TOM Y director, 10 percent owner, off..
Common Stock 13,250 $0.18 $2,372
Purchase
LEE TOM Y director, 10 percent owner, off..
Common Stock 21,227 $0.18 $3,821
Purchase
LEE TOM Y director, officer: Chief Execut..
Common Stock 35,998 $0.43 $15,515
Purchase
LEE TOM Y director, officer: Chief Execut..
Common Stock 851 $0.65 $553
Purchase
LEE TOM Y director, officer: Chief Execut..
Common Stock 45,299 $0.66 $29,988
Purchase
LEE TOM Y director, officer: Chief Execut..
Common Stock 7,859 $0.68 $5,344
Insider Compensation
Mr. Thomas Richard Myers (1952) Chief Operating Officer & Director $200,000
Mr. Mark Stuart Elliott (1975) Vice President of Fin. and Principal Financial & Accounting Officer $162,000
Mr. Tom Y. Lee CPA (1949) Chief Executive Officer, Pres & Director
$64,000
  • What's the price of PURE Bioscience stock today?

    One share of PURE Bioscience stock can currently be purchased for approximately $0.09.

  • When is PURE Bioscience's next earnings date?

    PURE Bioscience, Inc. is estimated to report earnings on Monday, 27 Oct 2025.

  • Does PURE Bioscience pay dividends?

    No, PURE Bioscience does not pay dividends.

  • How much money does PURE Bioscience make?

    PURE Bioscience has a market capitalization of 11.13M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 4.58% to 1.96M US dollars.

  • What is PURE Bioscience's stock symbol?

    PURE Bioscience, Inc. is traded on the OTC under the ticker symbol "PURE".

  • What is PURE Bioscience's primary industry?

    Company operates in the Consumer Defensive sector and Household & Personal Products industry.

  • How do i buy shares of PURE Bioscience?

    Shares of PURE Bioscience can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are PURE Bioscience's key executives?

    PURE Bioscience's management team includes the following people:

    • Mr. Thomas Richard Myers Chief Operating Officer & Director(age: 73, pay: $200,000)
    • Mr. Mark Stuart Elliott Vice President of Fin. and Principal Financial & Accounting Officer(age: 50, pay: $162,000)
    • Mr. Tom Y. Lee CPA Chief Executive Officer, Pres & Director(age: 76, pay: $64,000)
  • How many employees does PURE Bioscience have?

    As Jul 2024, PURE Bioscience employs 11 workers.

  • When PURE Bioscience went public?

    PURE Bioscience, Inc. is publicly traded company for more then 12 years since IPO on 13 May 2013.

  • What is PURE Bioscience's official website?

    The official website for PURE Bioscience is purebio.com.

  • Where are PURE Bioscience's headquarters?

    PURE Bioscience is headquartered at 9669 Hermosa Avenue, Rancho Cucamonga, CA.

  • How can i contact PURE Bioscience?

    PURE Bioscience's mailing address is 9669 Hermosa Avenue, Rancho Cucamonga, CA and company can be reached via phone at +61 95968600.

PURE Bioscience company profile:

PURE Bioscience, Inc.

purebio.com
Exchange:

OTC

Full time employees:

15

Industry:

Household & Personal Products

Sector:

Consumer Defensive

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.

9669 Hermosa Avenue
Rancho Cucamonga, CA 91730

CIK: 0001006028
ISIN: US74621T2096
: